Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers.

Thorat, Dhanashri; Sahu, Asutosh; Behera, Reeti; Lohite, Kirti; Deshmukh, Sanjay; Mane, Anupama; Karnik, Swapnil; Doke, Suhaschandra; Kundu, Gopal C

Thorat, Dhanashri; Sahu, Asutosh; Behera, Reeti; Lohite, Kirti; Deshmukh, Sanjay; Mane, Anupama; Karnik, Swapnil; Doke, Suhaschandra; Kundu, Gopal C.

Afiliación

Thorat D; Department of Tumor Biology, Angiogenesis and Nanomedicine, National Centre for Cell Science, Pune, Maharashtra 411007, India.

Oncol Lett ; 6(6): 1559-1564, 2013 Dec.

Article en En | MEDLINE | ID: mdl-24260046

Palabras clave

TNM staging; breast cancer subtypes; estrogen receptor; human epidermal growth factor receptor type 2; invasive ductal carcinoma; progesterone receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2013 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google